Investors welcomed a ceasefire in Ukraine but cybersecurity concerns weighed down technology stocks. The markets traded mixed during the midday with the Dow gaining 43 points to 17,111 while Nasdaq fell 15 points to 4583.
On the upside
Morgan Stanley analyst Ravi Shanker said that Mobileye (NYSE: MBLY) had the potential to climb to $100 a share.
Blyth (NYSE: BTH) will sell the majority of its holdings in ViSalus and retain a 10% ownership.
Tetraphase Pharmaceuticals (Nasdaq: TTPH) reported positive results from the lead-in portion of a Phase 3 clinical trial of its complicated urinary tract.
On the downside
Marrone Bio Innovations (Nasdaq: MBII) commenced an internal audit investigation.
The Wet Seal (Nasdaq: WTSL) replaced chief executive John Goodman with former CEO Edmond Thomas.
Profit taking sank shares of Repros Therapeutics (Nasdaq: RPRX).
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 added a point to 2003. Bitcoin slipped $2 to $474.
